PR Newswire PharmaOriginal article
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
EarningsLeqembiNeutral
AI Analysis
Summary
BioArctic AB's partner Eisai reported Leqembi sales of 29.3 billion yen in Q2 2026, released alongside Biogen's quarterly earnings report.
Financial Highlights
Revenue
JPY 29.3 billion
Outcome Details
Q2 2026 revenue reported for Leqembi
Importance:5/10
Sentiment:
0.00
earningsrevenuepartnershipQ2 2026
Related Companies
Read the original article
Published by PR Newswire Pharma on July 29, 2026 10:30 AM